Drug
APD791
APD791 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 2 completed trials
Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(50%)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Completed2
Terminated2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
completed250%
terminated250%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_1
A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers
NCT00619931
terminatedphase_1
Dose-escalation, Repeated and Single Oral Dosing Study
NCT02419820
terminatedphase_1
Safety Study of APD-791 With Aspirin and/or Clopidogrel
NCT02034292
completedphase_1
Single-Dose Safety Study of APD791 in Healthy Volunteers
NCT00529646
Clinical Trials (4)
Showing 4 of 4 trials
NCT00619931Phase 1
A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers
NCT02419820Phase 1
Dose-escalation, Repeated and Single Oral Dosing Study
NCT02034292Phase 1
Safety Study of APD-791 With Aspirin and/or Clopidogrel
NCT00529646Phase 1
Single-Dose Safety Study of APD791 in Healthy Volunteers
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4